Nymox Pharmaceutical (NYMX) Reports First Quarter 2013 Financial Results
5/15/2013 9:00:20 AM
More...
|
Nymox Pharmaceutical (NYMX) Reports on Symposium and Panel Discussion on NX-1207 at American Urological Association Annual Meeting
5/6/2013 9:10:32 AM
More...
|
Nymox Pharmaceutical (NYMX) NX-1207 Symposium May 5 in San Diego at Annual Meeting of American Urological Association at San Diego Convention Center
4/30/2013 2:31:41 PM
More...
|
Nymox Pharmaceutical (NYMX) Announces First Patient Enrollment for NX02-0022 Reinjection Study of NX-1207 for BPH
4/23/2013 11:17:40 AM
More...
|
Nymox Pharmaceutical (NYMX) NX-1207 BPH and Prostate Cancer Symposium at American Urological Association Annual Meeting May 5 in San Diego
4/11/2013 2:39:50 PM
More...
|
Nymox Pharmaceutical (NYMX)'s NicAlert™ Has Achieved Widespread Acceptance in Tobacco-Related Research Studies
3/27/2013 10:37:43 AM
More...
|
Nymox Pharmaceutical (NYMX) Announces Presentation of NX-1207 Data at Annual Meeting of the European Association of Urology
3/18/2013 11:28:05 AM
More...
|
Nymox Pharmaceutical (NYMX) Reports 2012 Financial Results
3/15/2013 11:18:53 AM
More...
|
Nymox Pharmaceutical (NYMX) Announces Upcoming Presentation of NX-1207 Data at European Association of Urology Congress
3/15/2013 11:13:39 AM
More...
|
Nymox Pharmaceutical (NYMX) Announces New Positive Results in Phase 3 Repeat Injection Study of NX-1207 for BPH
1/23/2013 8:56:03 AM
More...
|
|